Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) EPS (Basic) (2016 - 2019)

Historic EPS (Basic) for AC Immune (ACIU) over the last 3 years, with Q3 2019 value amounting to $19.8 million.

  • AC Immune's EPS (Basic) changed N/A to $19.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $19.8 million, marking a year-over-year change of. This contributed to the annual value of -$0.58 for FY2024, which is 1931.11% up from last year.
  • Latest data reveals that AC Immune reported EPS (Basic) of $19.8 million as of Q3 2019.
  • AC Immune's EPS (Basic)'s 5-year high stood at $67.6 million during Q1 2019, with a 5-year trough of -$25.2 million in Q2 2019.
  • Moreover, its 3-year median value for EPS (Basic) was $23.1 (2016), whereas its average is $10.4 million.
  • Examining YoY changes over the last 5 years, AC Immune's EPS (Basic) showed a top increase of 2602.22% in 2016 and a maximum decrease of 2602.22% in 2016.
  • Quarter analysis of 3 years shows AC Immune's EPS (Basic) stood at -$0.13 in 2015, then grew by 26.02% to -$0.1 in 2016, then soared by 20804582623.12% to $19.8 million in 2019.
  • Its EPS (Basic) stands at $19.8 million for Q3 2019, versus -$25.2 million for Q2 2019 and $67.6 million for Q1 2019.